Steve Pakola sold $689k of RGNX
Chief Medical Officer at REGENXBIO Inc.. 56,333 shares at an average of $12.23, traded Jun 29, 2026, filed Jul 1, 2026.
Score components
- +15RoleOfficer
- +21Trade size$689k at market
- +5Share of holdings soldSold 24% of holdings
- 0ClusterNo other insider selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001700659-26-000012, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Jun 29, 2026 | SOpen-market sale Common Stock10b5-1 | -19,608 | $11.04 | $216k | 213,009 | Jul 1, 2026 |
| Jul 1, 2026 | MOption exercise Common Stock10b5-1 | +36,725 | $7.86 | $289k | 249,734 | Jul 1, 2026 |
| Jul 1, 2026 | SOpen-market sale Common Stock10b5-1 | -36,725 | $12.86 | $472k | 213,009 | Jul 1, 2026 |
| Jul 1, 2026 | MOption exercise Stock Options (Right to Buy)derivative10b5-1 | -36,725 | $0.00 | $0 | 66,973 | Jul 1, 2026 |
Related signals
Other insiders at REGENXBIO Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 57Moderate | RGNXbuy REGENXBIO Inc. | Gregory Austin Ciongoli director | $949k 102,603 shares | +665% | |
| 0Weak | REGENXBIO Inc. | Steve Pakola Chief Medical Officer | $29k 2,161 shares | -1% | |
| 6Weak | REGENXBIO Inc. | Steve Pakola Chief Medical Officer | $169k 15,309 shares | -6% | |
| 2Weak | REGENXBIO Inc. | Steve Pakola Chief Medical Officer | $53k 5,124 shares | -2% | |
| 18Weak | REGENXBIO Inc. | Curran Simpson Chief Executive Officer | $263k 20,811 shares | -9% | |
| 13Weak | REGENXBIO Inc. | Curran Simpson Chief Executive Officer | $76k 7,624 shares | -3% | |
| 13Weak | REGENXBIO Inc. | Curran Simpson Chief Executive Officer | $77k 7,734 shares | -3% | |
| 0Weak | REGENXBIO Inc. | Kenneth T. Mills President and CEO | $163k 20,602 shares | -4% | |
| 0Weak | REGENXBIO Inc. | Argeris N Karabelas director | $101k 10,000 shares | -47% | |
| 0Weak | REGENXBIO Inc. | Argeris N Karabelas director | $116k 10,000 shares | -47% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.